OTLK Outlook Therapeutics, Inc.

1d ago, source: Seeking Alpha

Outlook Therapeutics, Inc., operates as a clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. Its lead ...

STOK Stoke Therapeutics, Inc.

1d ago, source: Seeking Alpha

Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its ...

Kim P. Kamdar's Net Worth

8d ago, source: Benzinga.com

Who is Kim P. Kamdar? Kim P. Kamdar has an estimated net worth of $2.25 Million. This is based on reported shares across multiple companies, which include MARINUS PHARMACEUTICALS INC, GLAUKOS Corp ...

Abeona Therapeutics Inc

4d ago, source: U.S. News & World Report

Here's an overview of some of the best bond ETFs to buy right now, according to experts.

Analysts Offer Insights on Healthcare Companies: Shattuck Labs (STTK) and Acrivon Therapeutics, Inc. (ACRV)

2d ago, source:

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Shattuck Labs (STTK – Research Report) and ...

Aldevron Announces Strategic Partnership with Acuitas Therapeutics

3d ago, source: Business Wire

Aldevron, a leading global manufacturer of DNA, RNA, and proteins used in cell and gene therapies and vaccine development, ...

Cara Therapeutics, Inc. (CARA)

3d ago, source: Yahoo Finance

May 13, 2024 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a development-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of patients suffering ...

Revance Therapeutics, Inc. (RVNC)

6d ago, source: Yahoo Finance

Revance Therapeutics, Inc. (NASDAQ:RVNC) Q1 2024 Earnings Call Transcript May 9, 2024 Revance Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third ...

TG Therapeutics Inc TGTX

8d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

HighTide Therapeutics Inc HTTIF

3d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...